SWOG clinical trial number
SWOG-9324

Phase II Trial of Vinorelbine Tartrate (Navelbine®) for Patients with Relapsed Ovarian Cancer

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Phase II Trial of Vinorelbine Tartrate (Navelbine®) for Patients with Relapsed Ovarian Cancer
Activated
03/15/1995
Closed
07/01/1997

Research committees

Gynecologic Cancer

Publication Information Expand/Collapse

2014

Enhancing nurse contributions to SWOG clinical trials

L Hansen;C Moinpour;R Ermete Seminars in Nursing Oncology 30(1):26-31;

PMid: PMID24559777 | PMC number: PMC3961058

2004

Phase II trial of vinorelbine for relapsed ovarian cancer. A Southwest Oncology Group Study

ML Rothenberg;PY Liu;S Wilczynski;WA Nahhas;GL Winakur;C Jiang;CM Moinpour;B Lyons;GR Weiss;JH Essell;HO Smith;M Markman;DS Alberts Gynecologic Oncology 95:506-512

2002

HRQL outcomes in a phase II trial for patients with recurrent ovarian cancer: was palliation achieved?

CM Moinpour;B Lyons;S McCoy;GL Winakur;PY Liu;ML Rothenberg Quality of Life Research 11(7):660(#157)

1999

A phase II trial of vinorelbine in relapsed and refractory ovarian cancer - A Southwest Oncology Group study (SWOG-9324).

ML Rothenberg;PY Liu;WA Nahhas;GR Weiss;LE Schroder;L Elias;S Wilczynski;G Winakur;DS Alberts Proc of the American Society of Clinical Oncology 18:383a(#1480)